[1] Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 2020;183(7):1901 − 12.e9. http://dx.doi.org/10.1016/j.cell.2020.10.049CrossRef
[2] Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu XT, et al. Persistence and Evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med 2020;383(23):2291 − 3. http://dx.doi.org/10.1056/NEJMc2031364CrossRef
[3] McKie AM, Jones TPW, Sykes C. Prolonged viral shedding in an immunocompetent patient with COVID-19. BMJ Case Rep 2020;13(10):e237357. http://dx.doi.org/10.1136/bcr-2020-237357CrossRef
[4] Liang X, Feng Z, Li L. Guidance for corona virus disease 2019: prevention, control, diagnosis and management: people’s medical publishing house; WHO collaborating centre for health information and publishing. 2020. http://www.gov.cn/zhengce/zhengceku/2021-04/15/content_5599795.htm. (In Chinese).  [2021-1-15].http://www.gov.cn/zhengce/zhengceku/2021-04/15/content_5599795.htm
[5] Rambaut A, Holmes EC, O'Toole Á, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol 2020;5(11):1403 − 7. http://dx.doi.org/10.1038/s41564-020-0770-5CrossRef
[6] Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang JW, Cao B, et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect 2021;27(3):315 − 8. http://dx.doi.org/10.1016/j.cmi.2020.11.028CrossRef
[7] Day T, Gandon S, Lion S, Otto SP. On the evolutionary epidemiology of SARS-CoV-2. Curr Biol 2020;30(15):R849 − 57. http://dx.doi.org/10.1016/j.cub.2020.06.031CrossRef
[8] Tang XL, Wu CC, Li X, Song YH, Yao XM, Wu XK, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev 2020;7(6):1012 − 23. http://dx.doi.org/10.1093/nsr/nwaa036CrossRef
[9] Lu J, Peng JJ, Xiong QL, Liu Z, Lin HF, Tan XH, et al. Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR. EBioMedicine 2020;59:102960. http://dx.doi.org/10.1016/j.ebiom.2020.102960CrossRef
[10] Wong J, Koh WC, Momin RN, Alikhan MF, Fadillah N, Naing L. Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: evidence from Brunei Darussalam. J Med Virol 2020;92(11):2847 − 51. http://dx.doi.org/10.1002/jmv.26199CrossRef
[11] Xu KJ, Chen YF, Yuan J, Yi P, Ding C, Wu WR, et al. Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clin Infect Dis 2020;71(15):799 − 806. http://dx.doi.org/10.1093/cid/ciaa351CrossRef
[12] Zheng SF, Fan J, Yu F, Feng BH, Lou B, Zou QD, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 2020;369:m1443. http://dx.doi.org/10.1136/bmj.m1443CrossRef
[13] Wang XL, Guo XH, Xin QQ, Pan Y, Hu YL, Li J, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients. Clin Infect Dis 2020;71(10):2688 − 94. http://dx.doi.org/10.1093/cid/ciaa721CrossRef
[14] Zhang LG, Richards A, Khalil A, Wogram E, Ma HT, Young RA, et al. SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome. bioRxiv 2020. http://dx.doi.org/10.1101/2020.12.12.422516CrossRef